Sassi Nir (CIK 1760673) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-29). Recent activity: Buy INDP (26,758 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-29 | Indaptus Therapeutics, Inc. (INDP) | Chief Financial Officer | Buy | 26,758 | $54,319 |
Source: SEC Form 4 filings · as of 2025-12-29